Business Context and Reporting Period
Company: Healthpeak Properties, Inc. (NYSE: DOC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 14, 2025
Event: Completion of an underwritten offering of senior notes by Healthpeak OP, LLC, a subsidiary of the Company.
Key Financial Metrics
| Metric | Value |
|---|---|
| Aggregate Principal Amount of Notes | $500.0 million |
| Coupon Rate | 5.375% |
| Maturity Date | February 15, 2035 |
| Estimated Net Proceeds | Approximately $493.2 million |
| Interest Payment Frequency | Semi-annually (February 15 and August 15) |
| First Interest Payment Date | August 15, 2025 |
Material Changes and Capital Structure
The Company has increased its long-term debt obligations through the issuance of the new 5.375% Senior Notes due 2035. The Notes are senior unsecured obligations of Healthpeak OP, LLC and are fully and unconditionally guaranteed on a joint and several basis by Healthpeak Properties, Inc., DOC DR Holdco, LLC, and DOC DR, LLC.
Use of Proceeds: The net proceeds are intended to:
- Repay borrowings outstanding under the Company's commercial paper program.
- Fund general corporate purposes, including potential repayment or repurchase of other indebtedness, working capital, acquisitions, development/redevelopment activities, and capital expenditures.
Prior to application, proceeds may be invested in short-term securities.
Guidance, Outlook, and Terms
Redemption Terms:
- Pre-Par Call Date (Before November 15, 2034): Healthpeak OP may redeem the Notes at a price equal to the greater of (i) the make-whole price (present value of remaining payments discounted at the Treasury Rate plus 20 basis points) or (ii) 100% of the principal amount, plus accrued interest.
- On or After Par Call Date (November 15, 2034): Healthpeak OP may redeem the Notes at 100% of the principal amount plus accrued interest.
Subordination: The Notes are effectively junior to existing and future secured indebtedness to the extent of the collateral securing such indebtedness and are structurally subordinated to liabilities of subsidiaries that do not guarantee the notes.
Management Commentary: The filing does not provide specific forward-looking guidance on revenue, profit, or cash flow projections beyond the immediate use of proceeds for debt management and corporate purposes.
Investor Verification Checklist
- Verify the exact amount of commercial paper outstanding to be repaid with the $493.2 million in net proceeds.
- Review the Base Indenture (Exhibit 4.1) and First Supplemental Indenture (Exhibit 4.2) for specific covenants and default provisions.
- Confirm the current status of the Company's commercial paper program and any remaining capacity.
- Assess the impact of the new 5.375% interest rate on the Company's overall weighted average cost of debt.
- Check for any subsequent filings regarding the actual application of proceeds if not immediately used for commercial paper repayment.